Remicade Biosimilar Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-2197 | Report Format : | Status : Upcoming |

Abstract

Remicade Biosimilar Market: Overview

Biosimilar is a term that is used to define a biological product type that is very much similar to the drug that is already approved by the FDA; this product is known as the reference biological product. The Remicade is an antibody that is monoclonal and is used for the treatment of the Crohn’s disease in the patients. 

Remicade Biosimilar Market: Facts

The US FDA approved the Renflexis manufactured by the Samsung Bioepis. It is the infliximab biosimilar product infliximab-abda that is used for the multiple indications. It is the second FDA-approved biosimilar product. Remicade manufactured by Janssen Biotech Inc. was the reference product. The US FDA had approved Inflectra from Celltrion in the year 2016.

Remicade Biosimilar Market: Segmentation

The market for the Remicade biosimilar is fragmented into its disease indication and regions. On the basis of the indication of the diseases, the market is segregated into rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn’s disease, ankylosing spondylitis, and ulcerative colitis. Depending on the geographical regions, the market for the macadamia is divided into Latin America, Western Europe, the Middle East & Africa, North America, Eastern Europe, and Asia Pacific.

Remicade Biosimilar Market: Growth Factors

The factors that are driving the Remicade biosimilar market are the early expiry of the patents of the branded version, speedy reaction times owing to the intravenous mode of administration, increasing cases of the autoimmune diseases especially rheumatoid arthritis and plaque psoriasis, and the discounted pricing. The entry of the biosimilar version will improve the accessibility of the patients to the medicines and will also provide financial relief. There are factors that will restrain the growth of the market which include the side effects that are caused by the drug may be fatal and can lead to hospitalization. Others factors that are affecting the market growth are shortage of the FDA approved facilities that are required for the production of the drugs and the complex nature of the molecule.

Remicade Biosimilar Market: Regional Analysis

The region that is leading in the Remicade biosimilar market is Europe and the regions that are following are Latin America and Asia Pacific. The key reason that is driving the market in these regions is the introduction of the biosimilar version shortly after the patent expiry of the version that was branded. The speedy drug review process and the systematic approach towards the drug discovery will develop the revenue development in the regions of North America. In the Central and the South America there are strict laws for the approval procedures and stringent guidelines for the manufacturing of the drugs thus leading to the chances of developing strategies for the regional manufacturing and distribution of the Remicade biosimilars.

Remicade Biosimilar Market: Competitive Players

The key market players that are involved in the Remicade biosimilar market include Merck &Co., Celltrion Inc., Napp Pharmaceuticals, Janssen Biotech Inc., Pfizer Inc., Alvogen, and Nippon Kayaku.

Remicade Biosimilar Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Medical Robotic Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3639 | Report Format:

Global Medical Robotic Systems Market: Overview Medical robots help doctors to perform operations with more accuracy. Medical robotics is still an emerging field. There is a broad range of medical applications that have emerged, such as laboratory robots, surgical robots, remote surgery, telesur...Read More

Electronic Clinical Outcome Assessment (eCOA) Market by Type (Web Hosted, Licensed Enterprise, and Cloud-Based) and by Platform (Hospitals, CROs, Academic Institutes, Pharma & Biotech Organizations, and Medical Device Manufacturers): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Dec-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3637 | Report Format:

The report covers a forecast and an analysis of the electronic clinical outcome assessment (eCOA) market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restr...Read More

Home Rehabilitation Products and Services Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3635 | Report Format:

Global Home Rehabilitation Products and Services Market: Overview Rehabilitation programs help patients improve, maintain, and restore physical strength and mobility in institutional and home care settings. Rehabilitation products supports a set of home rehabilitation services mainly comprising ...Read More

Corporate Wellness Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3634 | Report Format:

Global Corporate Wellness Market: Overview Corporate Wellness programs are devised to support employees and understand their health risks along with pursuing their healthy behavior at the workplace as well as minimize expensed on the healthcare activities. Corporate wellness schemes consist of h...Read More

Sarcopenia Market by Supplement Type (Protein Supplement, Vitamin D & Calcium Supplement, and Vitamin B12 Supplement) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Hypermarket & Supermarket): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2024

Dec-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3631 | Report Format:

The report covers a forecast and an analysis for the sarcopenia market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the sarcopenia market al...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.